The CBD market today is explosive. Since the government’s opening of hemp for the public’s distribution in 2018, it is on its way to becoming the new darling of the market. Sales have been at an all-time high during COVID-19’s health fears, revealing the amazing benefits CBD provides, including pain relief, anti-inflammation, and stress relief. Because of the convenience of production in the United States from legally allowing hemp-derived product distribution, CBD is becoming a highly sought after remedy to the consumer’s ailments.
One major player in the game is CanaFarma Hemp Product Corp. who operates a 55-acre farm in Dutchess County, New York. They are on track to become the market’s only vertically-integrated enterprise (a company who uses a visually vertical breakdown to plan operations of their raw materials to the customer) and will remain entirely in control of their CBD products, from the seed to final completion, placing them in the hands of their customers. In the CBD market, other organizations only focus on one aspect of the production, whether that be the cultivation, processing, marketing & sales, or research & info publication. CanaFarma, in comparison, is involved in the complete operation from start to finish, through a process called Seed-to-Counter.
CanaFarma’s Seed-to-Counter approach involves six cultivational measures in operation, that deliver the plants from their original state to products on the shelf. These six advantageous measures include CanaFarma’s independent hemp cultivation farm, processing facility, research staff, marketing team, information and marketplace portal, and distribution.
On CanaFarmas’ website, they explained saying, “Cultivating and processing our hemp will allow us to develop and accurately track the efficacy of countless formulations with different hemp strains and processing method combinations. Our relentless testing and research will permit us to create the best possible products for each segment of the CBD market.”